Merck & Co. (NYSE:MRK) Archives - Tech Stock Observer

Tag: Merck & Co. (NYSE:MRK)

Merck & Co. (NYSE:MRK) Signs Strategic Collaboration Agreement With Janux Therapeutics for T Cell Engager Immunotherapies

December 24, 2020 by Staff TechStockObserver 0 comments

Janux Therapeutics and Merck & Co. (NYSE:MRK) have entered a license and strategic collaboration agreement to discover, develop as well as commercialize next-gen T cell engager immunotherapies for cancer treatment. Merck to pay Janux $550.5 upfront payment following a collaboration agreement The collaboration aims to leverage Janux’s Novel Tumor Activated […]

Continue Reading →

Business

Merck & Co. (NYSE:MRK) Sells Its$125 Million Equity Stake In Moderna (NASDAQ:MRNA)

December 8, 2020 by Staff TechStockObserver 0 comments

Merck & Co. (NYSE:MRK) is cashing in on the meteoric rise of Moderna Inc. (NASDAQ:MRNA) in 2020 after the pharmaceutical giant dumped its equity stake in Moderna. Since the beginning of this year, Moderna, which is developing a potential COVID-19 vaccine, has gained over 620%. Merck sells its stake in […]

Continue Reading →

[Ad]

Tag: Merck & Co. (NYSE:MRK)

Merck & Co. (NYSE:MRK) Signs Strategic Collaboration Agreement With Janux Therapeutics for T Cell Engager Immunotherapies

Merck & Co. (NYSE:MRK) Sells Its$125 Million Equity Stake In Moderna (NASDAQ:MRNA)

Market Overview Widget

Sign Up!

Tech Stock Observer